RxDoctor Payments Data

Roberto Rodriguez, MD

Allergy · San Antonio, TXNPI 1821069550

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,768, 2.6 times the $684 reported in 2019.

$7,026in general payments, 2019–2025

Across 147 payments — averaging $47.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • GSK$1K
  • Sanofi$1K
  • Amgen$448
  • Sanofi-aventis U.S. LLC$371
  • Genentech USA, Inc.$338
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$6,94499%
  • Education$821%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,026 in reported general payments places this provider in the 65th percentile of 69 allergy providers in Texas.

See all allergy providers in Texas

Medicare billing

Part B allowed, 2024
$6,387
Medicare patients
64
Services billed
304

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$576
Montelukast Sodium43$362
Albuterol Sulfate HfaAlbuterol Sulfate14$313
Azelastine Hcl12$277
Prednisone27$39
Amoxicillin18$35

Paid to pharmacies, not to this prescriber.

Other allergy in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →